Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$522.38 +6.04 (+1.17%)
At close: Sep 24, 2026 · 4:00 PM EDT

Vertex Pharmaceuticals (VRTX) Total Debt Growth (3y) (2014 - 2017)

Analysis

Vertex Pharmaceuticals (VRTX) Total Debt Growth (3y) (2014 - 2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt Growth (3y) (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn 1.95%
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn 5.09%
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn 13.46%
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn 4.97%
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn -
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn -0.51%
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn -0.71%
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn -1.11%
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn -
10 Bristol Myers Squibb 124.95 Bn 113.89 Bn 9.25 Bn 3.06%
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 -7.62%
Sep 30, 2017 -13.57%
Sep 30, 2014 -0.32%
API Access

Vertex Pharmaceuticals Total Debt Growth (3y) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt-growth-3y&ticker=VRTX&period=max&api_key=YOUR_API_KEY